Jon Soderstrom is currently the Managing Director of the Office of Cooperative Research at Yale University. The Office manages the intellectual assets created at Yale to achieve the maximum benefit for the public and provide a financial return to support the University’s research efforts. He is responsible for managing the intellectual property portfolio of Yale faculty members, including (1) defining and executing commercialization strategies including negotiation of licenses and corporate-sponsored research agreements, (2) initiating strategic corporate partnerships, and (3) development and marketing of business concepts for new spin-off companies to the venture investment community. Since joining the Office in 1996, he has helped form more than 25 new ventures including Molecular Staging (acquired by Qiagen), Agilix, Achillion Pharmaceuticals (NASQ: ACHN), PhytoCeutica (acquired by Kadmon), Protometrix (acquired by Invitrogen), Iconic Therapeutics, Applied Spine Technologies, HistoRx (acquired by Genoptix), VaxInnate, Affomix, Kolltan Pharmaceuticals (acquired by Celldex), Arvinas and Artisan Bioscience. Collectively, these companies have raised over $500 million in professional venture capital. Prior to this position, Dr. Soderstrom was the Director of Program Development for Oak Ridge National Laboratory (ORNL) after serving for ten years as Director of Technology Licensing for Martin Marietta Energy Systems. In the Office of Technology Transfer, he directed a group of ten professionals responsible for negotiating licenses and Cooperative Research and Development Agreements (CRADAs).